Atlas Trials

Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma

Clinical trial NCT02006030 · COMPLETED

Trial details

NCT number
NCT02006030
Sponsor
Polaris Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Unresectable Hepatocellular Carcinoma
Start date
2014-10-15
Primary completion
2016-07-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.